Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge
about
Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis.EGFR-induced phosphorylation of type Iγ phosphatidylinositol phosphate kinase promotes pancreatic cancer progression.Norleual, a hepatocyte growth factor and macrophage stimulating protein dual antagonist, increases pancreatic cancer sensitivity to gemcitabine.c-Met affects gemcitabine resistance during carcinogenesis in a mouse model of pancreatic cancer.
P2860
Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge
@ast
Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge
@en
Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge
@nl
type
label
Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge
@ast
Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge
@en
Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge
@nl
prefLabel
Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge
@ast
Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge
@en
Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge
@nl
P2093
P2860
P356
P1433
P1476
Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge
@en
P2093
Amanda E Allen
Jose G Trevino
Wasia Rizwani
P2860
P304
P356
10.3390/CANCERS7030861
P407
P577
2015-01-01T00:00:00Z